Moderna (MRNA) Reports Publication of Phase 1 Data for mRNA Vaccines Against Two Potential Pandemic Influenza Strains

May 10, 2019 9:00 AM

Moderna, Inc., (NASDAQ: MRNA) today announced the publication of results from two Phase 1 clinical studies showing that mRNA vaccines ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found